期刊文献+

卡介苗接种后皮肤不良反应23例临床分析 被引量:5

Clinical analysis on adverse reaction of bacillus Calmette-Guérin vaccination
下载PDF
导出
摘要 目的总结卡介苗接种致不良反应的临床特征与治疗方法。方法收集2005年9月—2014年11月至我科就诊,并确诊为卡介苗接种后皮肤出现不良反应的患儿23例,对其自然信息、就诊后检查及治疗方案使用SPSS16.0统计软件分析处理数据及随访。结果男女比例为1.09∶1,1~3个月最多见(52.2%)。以皮肤表现(结节、斑块、脓肿)为主(23例),其次为淋巴结异常反应(8例,占25%)。治疗上皮损仅予对症治疗,伴淋巴结持续增大者口服异烟肼及利福平联合治疗。皮损于2~4个月愈合并遗留瘢痕。结论多数卡介苗接种后皮肤不良反应可通过外用药物及密切随访得到有效控制。 Objective To summarize the clinical characteristics and therapeutic schedule of bacillus Calmette-Guérin(BCG). Methods The general conditions,auxiliary examination and therapeutic schedule of 23 patients diagnosed as adverse reaction of BCG vaccination,from September 2005 to November 2014,were retrospectively analyzed by SPSS16.0 statistical software and followed up. Results The male and female ratio is 1.09:1,and 52.2% of the patients were in the age group of 1 to 3 month. Skin lesions were the mainly performance(23 cases,100%),followed by abnormal reactions of lymph nodes(8 cases,25%). Symptomatic treatment was given to the patients only with the skin lesions,and the patients with continued lymphadenectasis had been given the combined treatment of isoniazid and rifampicine. The natural history of these lesions is the ulceration formation and scarring that developed after 2 to 4 months from vaccination. Conclusion The adverse reaction of BCG vaccination need intervention and close outpatient follow-up.
出处 《实用皮肤病学杂志》 2015年第5期351-353,共3页 Journal of Practical Dermatology
关键词 卡介苗 不良反应 治疗方案 BCG Adverse reaction Therapeutic schedule
  • 相关文献

参考文献16

  • 1赵辨.中国临床皮肤病学[M].南京:江苏科学技术出版社,2009,12:744.
  • 2World Health Organization.BCG vaccine.WHO position paper[J].Wkly Epidemiol Rec,2004,79(4):27-38.
  • 3Calmette A,Guerin C.Sur quelques proprietds du bacilli tuberculeux d' origine,cultive sur la bile de boeuf glycerinee[J].CRAcad Sci,1909'149:716-718.
  • 4Hsu T,Hingley-Wilson SM,Chen B,et al.The primary mechanism of attenuation of bacillus Calmette-Guerin is a loss of secreted lytic function required for invasion of lung interstitial tissue[J].Proc Natl Acad Sci USA,2003,100(21):12420-12425.
  • 5Rosenthal SR,Loewinsohne,Graham ML,et al.BCG vaccination against tuberculosis in Chicago.A twenty-year study statistically analyzed[J].Pediatrics,1961,28:622-641.
  • 6Pereira SM,Barreto ML,Pilger D,et al.Effectiveness and cost- effectiveness of first BCG vaccination against tuberculosis in school-age children without previous tuberculin test (BCG- REVAC trial):a cluster-randomized trial[J].Lancet Infect Dis,2012,12(4):300-306.
  • 7Rodrigues LC,Mangtani P,Abubakar I.How does the level of BCG vaccine protection against tuberculosis fall over time?[J].BMJ,2011,343:d5974.
  • 8卢锦标,王国治.我国结核病疫苗和诊断制剂概述[J].中华结核和呼吸杂志,2014,37(6):461-463. 被引量:7
  • 9Lotte A,Wasz-Hockert O,Poisson N,et al.BCG complications.Estimates of the risks among vaccinated subjects and statistical analysis of their main characteristics[J].Adv Tuberc Res,1984,21:107-193.
  • 10Lotte A,Wasz-Hockert O,Poisson N,et al.Second IUATLD study on complications induced by intradermal BCG-vaccination[J].Bull Int Union Tuberc Lung Dis,1988,63(2):47-59.

二级参考文献12

共引文献409

同被引文献35

引证文献5

二级引证文献22

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部